StockData
CVRx, Inc. logo

CVRx, Inc. (CVRX) stock

CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.61−0.00 (-0.33%)

Close on Nov 17, 2026Market cap $16.28MP/E –Yield –

CVRx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CVRx's operating cash flow for the twelve months ending Jun 30, 2026 was -$40.46M. For fiscal 2025 it was -$40.17M. The highest annual figure on record is -$16.10M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$40.17M–
FY2024Dec 31, 2024-$39.14M–
FY2023Dec 31, 2023-$39.02M–
FY2022Dec 31, 2022-$42.68M–
FY2021Dec 31, 2021-$27.73M–
FY2020Dec 31, 2020-$16.10M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.83M–
Q1 FY2026Mar 31, 2026-$12.16M–
Q4 FY2025Dec 31, 2025-$9.76M–
Q3 FY2025Sep 30, 2025-$9.71M–
Q2 FY2025Jun 30, 2025-$7.94M–
Q1 FY2025Mar 31, 2025-$12.77M–
Q4 FY2024Dec 31, 2024-$8.01M–
Q3 FY2024Sep 30, 2024-$10.41M–
Q2 FY2024Jun 30, 2024-$9.83M–
Q1 FY2024Mar 31, 2024-$10.90M–
Q4 FY2023Dec 31, 2023-$7.84M–
Q3 FY2023Sep 30, 2023-$8.13M–
Q2 FY2023Jun 30, 2023-$12.81M–
Q1 FY2023Mar 31, 2023-$10.25M–
Q4 FY2022Dec 31, 2022-$10.84M–
Q3 FY2022Sep 30, 2022-$11.10M–
Q2 FY2022Jun 30, 2022-$10.10M–
Q1 FY2022Mar 31, 2022-$10.64M–
Q4 FY2021Dec 31, 2021-$7.02M–
Q3 FY2021Sep 30, 2021-$9.22M–
Q2 FY2021Jun 30, 2021-$6.46M–
Q1 FY2021Mar 31, 2021-$5.04M–
Q4 FY2020Dec 31, 2020-$4.08M–
Q3 FY2020Sep 30, 2020-$5.16M–

More CVRx figures

See a number that looks wrong?